Cart
sales@molnova.com
Thiamet G
CAS No. 1009816-48-1
Thiamet G( Thiamet G | Thiamet-G )
Catalog No. M17115 CAS No. 1009816-48-1
Thiamet G is a potent, selective O-GlcNAcase inhibitor with Kiof 21 nM, while exhibiting 37, 000-fold selectivity over human lysosomal –hexosaminidase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 54 | In Stock |
|
| 2MG | 35 | In Stock |
|
| 5MG | 54 | In Stock |
|
| 10MG | 89 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 336 | In Stock |
|
| 100MG | 499 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1107 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThiamet G
-
NoteResearch use only, not for human use.
-
Brief DescriptionThiamet G is a potent, selective O-GlcNAcase inhibitor with Kiof 21 nM, while exhibiting 37, 000-fold selectivity over human lysosomal –hexosaminidase.
-
DescriptionThiamet G is a potent and selective inhibitor of O-GlcNAcase.
-
In Vitro——
-
In Vivo——
-
SynonymsThiamet G | Thiamet-G
-
PathwayOthers
-
TargetOther Targets
-
RecptorO-GlcNAcase
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1009816-48-1
-
Formula Weight248.3
-
Molecular FormulaC9H16N2O4S
-
Purity>98% (HPLC)
-
SolubilityH2O : ≥ 50 mg/mL 201.37 mM DMSO : ≥ 45 mg/mL181.23 mM
-
SMILES[H][C@]12O[C@H](CO)[C@@H](O)[C@H](O)[C@@]1([H])N=C(NCC)S2
-
Chemical Name(3aR,5R,6S,7R,7aR)-2-(Ethylamino)-3a,6,7,7a-tetrahydro-5-(hydroxymethyl)-5H-pyrano[3,2-d]thiazole-6,7-diol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yuzwa SA, et al. Nat Chem Biol. 2008, 4(8), 483-490.
molnova catalog
related products
-
Butylphthalide
Butylphthalide is an anti-cerebral-ischemia drug; first isolated from the seeds of Apium graveolens Linn.
-
2-amino-4-methyl-1,3...
2-amino-4-methyl-1,3-thiazole-5-carbohydrazide is a compound used as a molecular building block.
-
Beta-Sitosterol
β-Sitosterol has recently been shown to induce G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways.
